754 related articles for article (PubMed ID: 18561467)
1. Exploring emerging nanobiotechnology drugs and medical devices.
Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
[No Abstract] [Full Text] [Related]
2. The coming era of nanomedicine.
Allhoff F
Am J Bioeth; 2009 Oct; 9(10):3-11. PubMed ID: 19998074
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine: developing smarter therapeutic and diagnostic modalities.
Farokhzad OC; Langer R
Adv Drug Deliv Rev; 2006 Dec; 58(14):1456-9. PubMed ID: 17070960
[TBL] [Abstract][Full Text] [Related]
4. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine.
Bawa R
IDrugs; 2007 Jul; 10(7):455-8. PubMed ID: 17642014
[No Abstract] [Full Text] [Related]
5. Nanomedicine: application of nanobiotechnology in medical practice.
Jain KK
Med Princ Pract; 2008; 17(2):89-101. PubMed ID: 18287791
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterials for biomedical applications.
Cao YC
Nanomedicine (Lond); 2008 Aug; 3(4):467-9. PubMed ID: 18694308
[No Abstract] [Full Text] [Related]
7. Medical devices on trial, Part I.
Wright D
Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
9. The need for rules and regulations.
Helmus MN
Nat Nanotechnol; 2007 Jun; 2(6):333-4. PubMed ID: 18654297
[No Abstract] [Full Text] [Related]
10. The role of nanobiotechnology in drug discovery.
Jain KK
Drug Discov Today; 2005 Nov; 10(21):1435-42. PubMed ID: 16243263
[TBL] [Abstract][Full Text] [Related]
11. The impact of nanobiotechnology on the development of new drug delivery systems.
Kayser O; Lemke A; Hernández-Trejo N
Curr Pharm Biotechnol; 2005 Feb; 6(1):3-5. PubMed ID: 15727551
[TBL] [Abstract][Full Text] [Related]
12. Particulate nanomedicines.
Moghimi SM; Kissel T
Adv Drug Deliv Rev; 2006 Dec; 58(14):1451-5. PubMed ID: 17081650
[No Abstract] [Full Text] [Related]
13. Nanomedicine: ethical concerns beyond diagnostics, drugs, and techniques.
McGee EM
Am J Bioeth; 2009 Oct; 9(10):14-5. PubMed ID: 19998076
[No Abstract] [Full Text] [Related]
14. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
Emerich DF; Thanos CG
Biomol Eng; 2006 Sep; 23(4):171-84. PubMed ID: 16843058
[TBL] [Abstract][Full Text] [Related]
15. Impact of nanoscience and nanotechnology on controlled drug delivery.
Youan BB
Nanomedicine (Lond); 2008 Aug; 3(4):401-6. PubMed ID: 18694301
[No Abstract] [Full Text] [Related]
16. [Nanobiotechnology and nanomedicine].
Medvedeva NV; Ipatova OM; Ivanov IuD; Drozhzhin AI; Archakov AI
Biomed Khim; 2006; 52(6):529-46. PubMed ID: 17288245
[TBL] [Abstract][Full Text] [Related]
17. Is nanotechnology ready for primetime?
Brower V
J Natl Cancer Inst; 2006 Jan; 98(1):9-11. PubMed ID: 16391365
[No Abstract] [Full Text] [Related]
18. The ability of current biologics law to accommodate emerging technologies.
Carter MJ
Food Drug Law J; 1996; 51(3):375-80. PubMed ID: 11797714
[No Abstract] [Full Text] [Related]
19. Beyond biotechnology: FDA regulation of nanomedicine.
Miller J
Columbia Sci Technol Law Rev; 2003; 4():E5. PubMed ID: 15977335
[TBL] [Abstract][Full Text] [Related]
20. A piece of history.
Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
